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Y outh with substance use disorders often also face mental health challenges. Two recent studies analyzed two different treatment approaches for co-occurring substance use and mental health disorders: (1) a standardized therapy approach and (2) 12-step support groups, as modalities for effectively treating and continuing positive outcomes for young people with co-occurring mental health and substance use is-sues. The findings from these studies are summarized below.
APPROACH 1: COGNITIVE BEHAVIORAL THERAPY  
AND MOTIVATIONAL ENHANCEMENT THERAPY
Cornelius and colleagues (2011) conducted a two-year follow up 
study on participants in two studies they had conducted previously to 
determine the long-term effects of using Cognitive Behavioral Therapy 
(CBT) and Motivational Enhancement Therapy (MET) together to 
address co-morbidity in adolescents. In one study, participants had 
received CBT/ MET to treat their co-morbid conditions. In the other 
study, participants received treatment as usual (TAU); this second study 
provided a naturalistic control group for the long-term follow up.
The authors described CBT as a therapy approach based on social 
learning models that focuses on developing an understanding of the 
triggers and consequences of drug use. They also stated that their 
implementation of CBT teaches coping skills to manage craving and 
other high-risk situations for use. The authors defined MET as an 
intervention used to increase an individual’s engagement in therapy 
using motivation to make beneficial changes around substance use and 
high-risk behaviors. This intervention specifically was chosen as a way 
to encourage treatment adherence in young people because, according 
to the study authors, young people with substance use disorders have 
historically possessed low rates of treatment engagement. 
At baseline, participants were between 15-20 years old and were 
diagnosed with both major depressive disorder (MDD) and an alcohol 
CBT/ MET can reduce both 
mental health symptoms 
and substance use in young 
people with co-occurring 
disorders two years after 
treatment. Young people 
who had high rates of  
participation in a 12-step 
program had higher levels of  
abstinence from alcohol and 
drugs years later.
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use disorder (AUD). Participants in the first study then 
received the intervention treatment of CBT/ MET, and 
those in study two received TAU. Those who received 
CBT/ MET received the treatment nine times over 
twelve weeks. Additionally, half of the intervention 
group also received Fluoxetine, an SSRI antidepressant 
medication. However, immediately after treatment 
there were no differences in mental health or substance 
use outcomes between the group that received the 
SSRI and the group that did not, so the two groups were 
combined in the long-term follow up. Other differences 
between those who received medication and those 
who did not were compared in a separate analysis.
Out of the 118 participants from the two initial 
studies, 75 completed the two-year follow up assess-
ment: 48 who had received CBT/ MET and 27 from the 
TAU study. Differences in substance use and depressive 
symptoms between the two groups at baseline and two 
years after treatment were assessed using repeated 
measures analysis of variance (ANOVA). 
Before the treatment phase, those in the CBT/ MET 
group demonstrated higher depressive symptomatol-
ogy than those in TAU. There were no differences 
between the two groups in terms of AUD. After two 
years, there were no differences in outcomes between 
those in the CBT/ MET group who received medica-
tion and those who did not. Long term follow up did 
indicate that both the intervention group and TAU 
group demonstrated decreased diagnostic criteria in 
both depressive symptoms and alcohol use between 
the two time points. However, those in the CBT/ MET 
group demonstrated significantly more improvements 
than those participants in the TAU group. More specifi-
cally, analyses found significantly decreased depressive 
symptoms on three assessments including the number 
of DSM criteria for MDD (f = 14.6, p = 0.000), the Beck 
Depression Inventory (f = 12.4, p = 0.001) and the 
Hamilton Depression Rating scale (f = 16.6, p = 0.000). 
A significantly greater improvement in the DSM criteria 
for alcohol use disorder was also found in the CBT/ MET 
group (f = 14.2, p = 0.000). 
These results demonstrate that, in combination, CBT 
and MET may be an effective treatment for adolescents 
diagnosed with both MDD and AUD. The effects of this 
approach lasted two years past treatment. The SSRI 
Fluoxetine did not appear effective when combined 
with CBT/ MET in either the short or long term for this 
particular group. However, the small sample size used 
to assess long term effectiveness is a limitation to this 
study and replication of its findings are warranted.
APPROACH 2: 12-STEP PROGRAMS
A study by Chi and colleagues (2013) examined the 
long-term effects of participating in a 12-step program 
on post-treatment substance use abstinence for youth 
with and without mental health challenges. 
Participants for this seven-year study (N=419) 
were recruited from four Kaiser Permanente Chemical 
Dependency Recovery Programs in California, and were 
aged 13-18 at baseline. This sample was 34% female, 
and race/ ethnic distribution was as follows: 50% of 
participants reported as Caucasian, 21% Hispanic, 14% 
African American, 8% Native American, and 6% Asian/ 
Pacific Islander.
Psychiatric diagnoses were taken from Kaiser 
Permanente’s inpatient and outpatient databases. 
Adolescents with co-occurring disorders were those 
who received at least one psychiatric diagnosis on 
the International Classification of Diseases (ICD)-9 in 
the two years prior to the study through six months 
after entering substance abuse treatment. Severity of 
symptoms was measured at intake by internalizing and 
externalizing scales on the Youth Self-Report question-
naire (YSR). Follow up evaluations were conducted by 
phone at one, three, five, and seven years after intake. 
To measure 12-step group participation, the Alco-
holics Anonymous (AA) Affiliation scale was modi-
fied to include Narcotics Anonymous (NA), Cocaine 
Anonymous (CA) and other 12-step groups. Meeting 
attendance was measured by the number of meetings 
attended in the six months prior to the assessment; 
activity involvement within the program (e.g., con-
sidering oneself a member, having a sponsor, having 
sponsored anyone, calling other members for help, 
etc.) was measured by adding up the total number of 
activities selected (scores ranging from 0 to a maximum 
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of 3+). Substance use was measured by assessing thirty-
day abstinence from alcohol and drug use measured at 
each time interval. 
Differences between adolescents with co-occurring 
disorders and those with only substance use issues 
were compared. At baseline, when compared to those 
who presented with only a substance use disorder, 
adolescents with co-occurring issues had higher levels 
of substance use, reported more abuse/ dependence 
symptoms and had higher YSR internalizing and exter-
nalizing scores. There were no differences in substance 
use treatment retention or length of stay between the 
two groups at any time intervals. However, 12-step 
meetings were more highly attended in years one and 
three by young people with co-occurring diagnoses 
than those who were just managing a substance use 
disorder (33% vs. 19%, p = .0032; and 16% vs. 7%, p = 
0.0106). Those with co-morbid conditions also reported 
being abstinent more often than those with SUD only. 
Analyses were conducted to examine the relation-
ship between post-treatment participation in 12-step 
groups and substance use outcomes for young people 
with both co-occurring and substance abuse-only 
diagnoses. Adolescents with and without co-occurring 
disorders who attended at least ten 12-step meetings in 
the prior six months of each measurement interval were 
more than three and five times as likely to be abstinent 
from alcohol at follow-ups as those who attended fewer 
or no meetings (OR = 3.02, P = .0049; and OR = 5.29, P 
=.0063, respectively). Adolescents in both groups who 
had high meeting attendance were also 5 times more 
likely to be abstinent from drugs. Similarly, those with 
and without co-occurring disorders who were more 
actively involved in their 12-step programs were more 
than twice and eight times as likely to be abstinent from 
alcohol over time as those with less involvement (OR = 
2.55, P = .0322; and OR = 8.17, P < .0001, respectively). 
Results from this study show that 12-step programs 
may help some young people with psychiatric and sub-
stance use issues maintain abstinence from substance 
use over the long-term. 
CONCLUSION
These two recent studies demonstrate promising 
initial results regarding the long-term effectiveness of 
various non-medicine based treatment approaches 
for supporting adolescents and young adults with co-
occurring disorders. The first study showed that CBT/ 
MET can reduce both mental health symptoms and sub-
stance use in young people with co-occurring disorders 
two years after treatment. The second study found that 
those young people with co-occurring disorders who 
had high rates of participation in a 12-step program 
had higher levels of abstinence from alcohol and drugs 
years later. However, more research needs to be done 
to replicate these findings and to better understand the 
best ways to treat young people who face both mental 
health and substance use challenges. 
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